語系/ Language:
繁體中文
English
KMU OLIS
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Glioma imagingphysiologic, metabolic...
~
SpringerLink (Online service)
Glioma imagingphysiologic, metabolic, and molecular approaches /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Glioma imaging/ edited by Whitney B. Pope.
其他題名:
physiologic, metabolic, and molecular approaches /
其他作者:
Pope, Whitney B.
出版者:
Cham :Springer International Publishing : : 2020.,
面頁冊數:
xiv, 286 p. :ill., digital ; : 24 cm.;
提要註:
This book covers physiologic, metabolic and molecular imaging for gliomas. Gliomas are the most common primary brain tumors. Imaging is critical for glioma management because of its ability to noninvasively define the anatomic location and extent of disease. While conventional MRI is used to guide current treatments, multiple studies suggest molecular features of gliomas may be identified with noninvasive imaging, including physiologic MRI and amino acid positron emission tomography (PET) These advanced imaging techniques have the promise to help elucidate underlying tumor biology and provide important information that could be integrated into routine clinical practice. The text outlines current clinical practice including common scenarios in which imaging interpretation impacts patient management. Gaps in knowledge and potential areas of advancement based on the application of more experimental imaging techniques will be discussed. In reviewing this book, readers will learn: current standard imaging methodologies used in clinical practice for patients undergoing treatment for glioma and the implications of emerging treatment modalities including immunotherapy the theoretical basis for advanced imaging techniques including diffusion and perfusion MRI, MR spectroscopy, CEST and amino acid PET the relationship between imaging and molecular/genomic glioma features incorporated in the WHO 2016 classification update and the potential application of machine learning about the recently adopted and FDA approved standard brain tumor protocol for multicenter drug trials of the gaps in knowledge that impede optimal patient management and the cutting edge imaging techniques that could address these deficits.
Contained By:
Springer eBooks
標題:
Oncology. -
電子資源:
https://doi.org/10.1007/978-3-030-27359-0
ISBN:
9783030273590
Glioma imagingphysiologic, metabolic, and molecular approaches /
Glioma imaging
physiologic, metabolic, and molecular approaches /[electronic resource] :edited by Whitney B. Pope. - Cham :Springer International Publishing :2020. - xiv, 286 p. :ill., digital ;24 cm.
1. Indications and Limitations of Conventional Imaging - Current Clinical Practice in the Context of Standard Therapy -- 2. Surrogates for Disease Status - Contrast Enhancement Including Limitations of Pseudoprogression and Pseudoresponse -- 3. The Relationship Between Biological and Imaging Characteristics in Enhancing and Nonenhancing Glioma -- 4. Contrast-Enhanced T1-Weighted Digital Subtraction for Increased Lesion Conspicuity and Quantifying Treatment Response in Malignant Gliomas -- 5. Advanced Physiologic Imaging: Perfusion. Theory and Applications -- 6. Advanced Physiologic Imaging: Diffusion. Theory and Applications -- 7. Parametric Response Map (PRM) Analysis Improves Response Assessment in Gliomas -- 8. Review of WHO 2016 Changes to Classification of Gliomas; Incorporation of Molecular Markers -- 9. Imaging markers of Low Grade Diffuse Glioma -- 10. CEST, pH and Glucose Imaging as Markers for Hypoxia and Malignant Transformation -- 11. MRS for D-2HG Detection in IDH Mutant Glioma -- 12. C-13 Hyperpolarized MR Spectroscopy for Metabolic Imaging of Brain Tumors -- 13. FET and FDOPA PET Imaging in Glioma -- 14. Imaging Genomics -- 15. Radiomics and Machine Learning -- 16. Immunotherapy and Gliomas -- 17. The Path Forward -The Standardized Brain Tumor Imaging Protocol (BTIP) for Multicenter Trials.
This book covers physiologic, metabolic and molecular imaging for gliomas. Gliomas are the most common primary brain tumors. Imaging is critical for glioma management because of its ability to noninvasively define the anatomic location and extent of disease. While conventional MRI is used to guide current treatments, multiple studies suggest molecular features of gliomas may be identified with noninvasive imaging, including physiologic MRI and amino acid positron emission tomography (PET) These advanced imaging techniques have the promise to help elucidate underlying tumor biology and provide important information that could be integrated into routine clinical practice. The text outlines current clinical practice including common scenarios in which imaging interpretation impacts patient management. Gaps in knowledge and potential areas of advancement based on the application of more experimental imaging techniques will be discussed. In reviewing this book, readers will learn: current standard imaging methodologies used in clinical practice for patients undergoing treatment for glioma and the implications of emerging treatment modalities including immunotherapy the theoretical basis for advanced imaging techniques including diffusion and perfusion MRI, MR spectroscopy, CEST and amino acid PET the relationship between imaging and molecular/genomic glioma features incorporated in the WHO 2016 classification update and the potential application of machine learning about the recently adopted and FDA approved standard brain tumor protocol for multicenter drug trials of the gaps in knowledge that impede optimal patient management and the cutting edge imaging techniques that could address these deficits.
ISBN: 9783030273590
Standard No.: 10.1007/978-3-030-27359-0doiSubjects--Topical Terms:
273823
Oncology.
LC Class. No.: RC280.B7 / G556 2020
Dewey Class. No.: 616.99481
Glioma imagingphysiologic, metabolic, and molecular approaches /
LDR
:04057nam a2200337 a 4500
001
338151
003
DE-He213
005
20200320142303.0
006
m d
007
cr nn 008maaau
008
210622s2020 sz s 0 eng d
020
$a
9783030273590
$q
(electronic bk.)
020
$a
9783030273583
$q
(paper)
024
7
$a
10.1007/978-3-030-27359-0
$2
doi
035
$a
978-3-030-27359-0
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC280.B7
$b
G556 2020
072
7
$a
MMPH
$2
bicssc
072
7
$a
MED008000
$2
bisacsh
072
7
$a
MKSH
$2
thema
072
7
$a
MKS
$2
thema
082
0 4
$a
616.99481
$2
23
090
$a
RC280.B7
$b
G561 2020
245
0 0
$a
Glioma imaging
$h
[electronic resource] :
$b
physiologic, metabolic, and molecular approaches /
$c
edited by Whitney B. Pope.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2020.
300
$a
xiv, 286 p. :
$b
ill., digital ;
$c
24 cm.
505
0
$a
1. Indications and Limitations of Conventional Imaging - Current Clinical Practice in the Context of Standard Therapy -- 2. Surrogates for Disease Status - Contrast Enhancement Including Limitations of Pseudoprogression and Pseudoresponse -- 3. The Relationship Between Biological and Imaging Characteristics in Enhancing and Nonenhancing Glioma -- 4. Contrast-Enhanced T1-Weighted Digital Subtraction for Increased Lesion Conspicuity and Quantifying Treatment Response in Malignant Gliomas -- 5. Advanced Physiologic Imaging: Perfusion. Theory and Applications -- 6. Advanced Physiologic Imaging: Diffusion. Theory and Applications -- 7. Parametric Response Map (PRM) Analysis Improves Response Assessment in Gliomas -- 8. Review of WHO 2016 Changes to Classification of Gliomas; Incorporation of Molecular Markers -- 9. Imaging markers of Low Grade Diffuse Glioma -- 10. CEST, pH and Glucose Imaging as Markers for Hypoxia and Malignant Transformation -- 11. MRS for D-2HG Detection in IDH Mutant Glioma -- 12. C-13 Hyperpolarized MR Spectroscopy for Metabolic Imaging of Brain Tumors -- 13. FET and FDOPA PET Imaging in Glioma -- 14. Imaging Genomics -- 15. Radiomics and Machine Learning -- 16. Immunotherapy and Gliomas -- 17. The Path Forward -The Standardized Brain Tumor Imaging Protocol (BTIP) for Multicenter Trials.
520
$a
This book covers physiologic, metabolic and molecular imaging for gliomas. Gliomas are the most common primary brain tumors. Imaging is critical for glioma management because of its ability to noninvasively define the anatomic location and extent of disease. While conventional MRI is used to guide current treatments, multiple studies suggest molecular features of gliomas may be identified with noninvasive imaging, including physiologic MRI and amino acid positron emission tomography (PET) These advanced imaging techniques have the promise to help elucidate underlying tumor biology and provide important information that could be integrated into routine clinical practice. The text outlines current clinical practice including common scenarios in which imaging interpretation impacts patient management. Gaps in knowledge and potential areas of advancement based on the application of more experimental imaging techniques will be discussed. In reviewing this book, readers will learn: current standard imaging methodologies used in clinical practice for patients undergoing treatment for glioma and the implications of emerging treatment modalities including immunotherapy the theoretical basis for advanced imaging techniques including diffusion and perfusion MRI, MR spectroscopy, CEST and amino acid PET the relationship between imaging and molecular/genomic glioma features incorporated in the WHO 2016 classification update and the potential application of machine learning about the recently adopted and FDA approved standard brain tumor protocol for multicenter drug trials of the gaps in knowledge that impede optimal patient management and the cutting edge imaging techniques that could address these deficits.
650
2 4
$2
96060
$a
Oncology.
$3
273823
650
1 4
$a
Imaging / Radiology.
$3
464935
650
0
$a
Brain
$x
Tumors.
$3
465043
650
0
$a
Gliomas
$x
Imaging.
$3
465843
700
1
$a
Pope, Whitney B.
$3
465842
710
2
$2
97100
$a
SpringerLink (Online service)
$3
255133
773
0
$t
Springer eBooks
856
4 0
$u
https://doi.org/10.1007/978-3-030-27359-0
950
$a
Medicine (Springer-11650)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得,請勿在此評論區張貼涉及人身攻擊、情緒謾罵、或內容涉及非法的不當言論,館方有權利刪除任何違反評論規則之發言,情節嚴重者一律停權,以維護所有讀者的自由言論空間。
Export
取書館別
處理中
...
變更密碼
登入